Glimepiride is a medication used to treat type 2 diabetes. It works by increasing the amount of insulin released by the pancreas, which helps to control blood sugar levels. While this medication can be effective in managing diabetes, it does have some potential side effects that should be taken into consideration. In this article, we will discuss the unseen risks of glimepiride and uncover the potential side effects.
Glimepiride is an oral medication used to treat type 2 diabetes. It belongs to a class of medications known as sulfonylureas, which work by stimulating the release of insulin from the pancreas. This helps to lower blood sugar levels and keep them in a normal range. Glimepiride is typically used in combination with diet and exercise to help control diabetes.
Like any medication, glimepiride can cause side effects. Common side effects of glimepiride include nausea, stomach pain, headache, dizziness, and drowsiness. These side effects are usually mild and may go away after a few days. However, more serious side effects can occur, including:
If any of these side effects occur, it is important to contact your doctor as soon as possible.
In addition to the more common side effects, there are some unseen risks associated with glimepiride. These risks include an increased risk of heart disease, stroke, and death.
Research has shown that glimepiride can increase the risk of heart disease. One study found that people taking glimepiride had a higher risk of heart attack, stroke, and death compared to those taking other diabetes medications. This risk is thought to be due to glimepiride’s ability to increase the levels of fat and cholesterol in the blood.
Another potential risk associated with glimepiride is an increased risk of stroke. Research has found that people taking glimepiride had a higher risk of ischemic stroke compared to those taking other diabetes medications. This risk is thought to be due to glimepiride’s ability to increase blood pressure.
Finally, glimepiride has been linked to an increased risk of death. One study found that people taking glimepiride had a higher risk of death compared to those taking other diabetes medications. This risk is thought to be due to glimepiride’s ability to increase the risk of heart disease and stroke.
Glimepiride is a medication used to treat type 2 diabetes. While it can be effective in managing diabetes, it does have some potential side effects that should be taken into consideration. In addition to more common side effects, there are some unseen risks associated with glimepiride, including an increased risk of heart disease, stroke, and death. It is important to discuss the potential risks and benefits of glimepiride with your doctor before starting this medication.
1.
More Positive Survival Data in Lung Cancer With Perioperative Therapy
2.
Upfront TKI for Bone-Predominant RCC Tops Single-Agent Immunotherapy
3.
Study finds 10% of pediatric blood cancers may stem from medical imaging radiation
4.
For the creation of cutting-edge targeted radionuclide therapies in oncology, Bayer and Bicycle Therapeutics work together.
5.
Pre-operative evaluation of ovarian cancer patients using DWI-MRI is helpful.
1.
Case Study: Artificial Intelligence in Early Cancer Detection
2.
Understanding Acute Intermittent Porphyria: Symptoms, Diagnosis and Treatment
3.
What is Mullerian and How Does it Affect Your Health
4.
AI in Cancer Care: Transforming Research & Treatment with Deep Learning Technologies
5.
Is p53 the Missing Puzzle Piece? Exploring Its Polymorphisms in Cervical Cancer Risk
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Should We Use DARA Up Front As First-Line Therapy in MM?
2.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part IV
3.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update)
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation